<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-116
Date of Submission: 2024-08-24

This report was submitted by a Nurse from Lawson, Miller and Wilson Medical Center concerning patient ANON-PX-8101. The subject is an adult male with a significant medical history including seasonal allergies, chronic kidney disease, type 2 diabetes. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Lisinopril administered via the Oral route at a dosage of 455mg, initiated on 2024-07-19 for Hypertension and discontinued on 2024-07-29.

On approximately 2024-07-27, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Maculopapular Rash, Hepatotoxicity. The Maculopapular Rash was classified as Moderate in severity. This necessitated clinical intervention. The documented action was: Prescribed contain and advised significant. The current patient status regarding this symptom is 'Recovering'. The Hepatotoxicity was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Rechallenge not performed'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Develop away third happy nearly. Yeah teacher situation part especially audience relationship. Hot might each dark.</data>
report_id: ADR-2024-116
report_date: '2024-08-24'
patient_details:
  patient_id: ANON-PX-8101
  gender: Male
  relevant_history:
  - seasonal allergies
  - chronic kidney disease
  - type 2 diabetes
suspected_drugs:
- drug_name: Lisinopril
  dosage: 455mg
  route_of_administration: Oral
  start_date: '2024-07-19'
  indication_for_use: Hypertension
  end_date: '2024-07-29'
adverse_reactions:
- symptom_name: Maculopapular Rash
  onset_date: '2024-07-27'
  severity: Moderate
  outcome: Recovering
  intervention_required: true
  intervention_details: Prescribed contain and advised significant.
- symptom_name: Hepatotoxicity
  onset_date: '2024-07-27'
  severity: Moderate
  outcome: Recovered
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Rechallenge not performed
reporting_facility: Lawson, Miller and Wilson Medical Center
reporter_type: Nurse
notes: Develop away third happy nearly. Yeah teacher situation part especially audience
  relationship. Hot might each dark.
